APA (7th ed.) Citation

Yang, J., Ambade, A. S., Nies, M., Griffiths, M., Damico, R., Vaidya, D., . . . Everett, A. D. (2022). Hepatoma‐derived growth factor is associated with pulmonary vascular remodeling and PAH disease severity and survival. Pulmonary Circulation, 12(1), 1. https://doi.org/10.1002/pul2.12007

Chicago Style (17th ed.) Citation

Yang, Jun, et al. "Hepatoma‐derived Growth Factor Is Associated with Pulmonary Vascular Remodeling and PAH Disease Severity and Survival." Pulmonary Circulation 12, no. 1 (2022): 1. https://doi.org/10.1002/pul2.12007.

MLA (9th ed.) Citation

Yang, Jun, et al. "Hepatoma‐derived Growth Factor Is Associated with Pulmonary Vascular Remodeling and PAH Disease Severity and Survival." Pulmonary Circulation, vol. 12, no. 1, 2022, p. 1, https://doi.org/10.1002/pul2.12007.